DiGeorge, A. Discussion on a new concept of the cellular immunology. J. Pediatr.67, 907–908 (1965). Article Google Scholar
Takao, A., Ando, M., Cho, K., Kinouchi, A. & Murakami, Y. in Etiology and Morphogenesis of Congenital Heart Disease (eds Van Praagh, R. & Takao, A. ) 253–269 (Futura Pub. Co., 1980). Google Scholar
Digilio, M. C., Marino, B., Formigari, R. & Giannotti, A. Maternal diabetes causing DiGeorge anomaly and renal agenesis. Am. J. Med. Genet.55, 513–514 (1995). ArticleCASPubMed Google Scholar
Sulik, K. K., Johnston, M. C., Daft, P. A., Russell, W. E. & Dehart, D. B. Fetal alcohol syndrome and DiGeorge anomaly: critical ethanol exposure periods for craniofacial malformations as illustrated in an animal model. Am. J. Med. Genet.Suppl.2, 97–112 (1986). ArticleCAS Google Scholar
Coberly, S., Lammer, E. & Alashari, M. Retinoic acid embryopathy: case report and review of literature. Pediatr. Pathol. Lab. Med.16, 823–836 (1996). ArticleCASPubMed Google Scholar
Sanlaville, D. et al. Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development. J. Med. Genet.43, 211–217 (2006). ArticleCASPubMed Google Scholar
Jyonouchi, S., McDonald-McGinn, D. M., Bale, S., Zackai, E. H. & Sullivan, K. E. CHARGE (coloboma, heart defect, atresia choanae, retarded growth and development, genital hypoplasia, ear anomalies/deafness) syndrome and chromosome 22q11.2 deletion syndrome: a comparison of immunologic and nonimmunologic phenotypic features. Pediatrics123, e871–e877 (2009). ArticlePubMed Google Scholar
Yagi, H. et al. Role of TBX1 in human del22q11.2 syndrome. Lancet362, 1366–1373 (2003). Mutations were identified inTBX1in two unrelated patients who do not have a 22q11.2 deletion but have some of the medical findings. This finding implicatesTBX1as a causative gene for 22q11.2DS. ArticleCASPubMed Google Scholar
Zweier, C., Sticht, H., Aydin-Yaylagul, I., Campbell, C. E. & Rauch, A. Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions. Am. J. Hum. Genet.80, 510–517 (2007). ArticleCASPubMedPubMed Central Google Scholar
Daw, S. C. et al. A common region of 10p deleted in DiGeorge and velocardiofacial syndromes. Nat. Genet.13, 458–460 (1996). This paper demonstrates that pathogenetic copy number variations elsewhere in the genome can cause similar phenotypes as in 22q11.2DS. ArticleCASPubMed Google Scholar
Grossfeld P. D. et al. The 11q terminal deletion disorder: a prospective study of 110 cases. Am. J. Med. Genet. A129A 51–61 (2004). ArticlePubMed Google Scholar
de la Chapelle, A., Herva, R., Koivisto, M. & Aula, P. A deletion in chromosome 22 can cause DiGeorge syndrome. Hum. Genet.57, 253–256 (1981). ArticleCASPubMed Google Scholar
Kelley, R. I. et al. The association of the DiGeorge anomalad with partial monosomy of chromosome 22. J. Pediatr.101, 197–200 (1982). This paper and reference 12 were seminal in elucidating the association of 22q11.2DS with the clinical features of DiGeorge syndrome. ArticleCASPubMed Google Scholar
Scambler, P. J. et al. Microdeletions within 22q11 associated with sporadic and familial DiGeorge syndrome. Genomics10, 201–206 (1991). The development of FISH probes, as described in this seminal paper and in reference 15, changed our understanding of both the prevalence and the breadth of clinical variability for 22q11.2DS. ArticleCASPubMed Google Scholar
Driscoll, D. A. et al. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis. J. Med. Genet.30, 813–817 (1993). ArticleCASPubMedPubMed Central Google Scholar
Burn, J. et al. Conotruncal anomaly face syndrome is associated with a deletion within chromosome 22q11. J. Med. Genet.30, 822–824 (1993). ArticleCASPubMedPubMed Central Google Scholar
Matsuoka, R. et al. Confirmation that the conotruncal anomaly face syndrome is associated with a deletion within 22q11.2. Am. J. Med. Genet.53, 285–289 (1994). ArticleCASPubMed Google Scholar
McDonald-McGinn, D. M. et al. Autosomal dominant ‘Opitz’ GBBB syndrome due to a 22q11.2 deletion. Am. J. Med. Genet.59, 103–113 (1995). ArticleCASPubMed Google Scholar
Giannotti, A., Digilio, M. C., Marino, B., Mingarelli, R. & Dallapiccola, B. Cayler cardiofacial syndrome and del 22q11: part of the CATCH22 phenotype. Am. J. Med. Genet.53, 303–304 (1994). ArticleCASPubMed Google Scholar
McDonald-McGinn, D. M. et al. The 22q11.2 deletion: screening, diagnostic workup, and outcome of results; report on 181 patients. Genet. Test.1, 99–108 (1997). ArticleCASPubMed Google Scholar
McDonald-McGinn, D. M., Zackai, E. H. & Low, D. What's in a name? The 22q11.2 deletion. Am. J. Med. Genet.72, 247–249 (1997). ArticleCASPubMed Google Scholar
Bassett, A. S. et al. Practical guidelines for managing patients with 22q11.2 deletion syndrome. J. Pediatr.159, 332–339.e331 (2011). ArticlePubMedPubMed Central Google Scholar
McDonald-McGinn, D. M. & Sullivan, K. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine90, 1–18 (2011). ArticlePubMed Google Scholar
Botto, L. D. et al. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics112, 101–107 (2003). ArticlePubMed Google Scholar
Devriendt, K., Fryns, J. P., Mortier, G., van Thienen, M. N. & Keymolen, K. The annual incidence of DiGeorge/velocardiofacial syndrome. J. Med. Genet.35, 789–790 (1998). ArticleCASPubMedPubMed Central Google Scholar
Goodship, J., Cross, I., LiLing, J. & Wren, C. A population study of chromosome 22q11 deletions in infancy. Arch. Dis. Child.79, 348–351 (1998). ArticleCASPubMedPubMed Central Google Scholar
Oskarsdottir, S., Vujic, M. & Fasth, A. Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden. Arch. Dis. Child.89, 148–151 (2004). ArticleCASPubMedPubMed Central Google Scholar
Té zenas Du Montcel, S., Mendizabai, H., Ayme, S., Levy, A. & Philip, N. Prevalence of 22q11 microdeletion. J. Med. Genet.33, 719 (1996). Article Google Scholar
McDonald-McGinn, D. M. et al. Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net! Genet. Med.3, 23–29 (2001). ArticleCASPubMed Google Scholar
Costain, G., Chow, E. W., Silversides, C. K. & Bassett, A. S. Sex differences in reproductive fitness contribute to preferential maternal transmission of 22q11.2 deletions. J. Med. Genet.48, 819–824 (2011). ArticlePubMed Google Scholar
Repetto, G. M. et al. Case fatality rate and associated factors in patients with 22q11 microdeletion syndrome: a retrospective cohort study. BMJ Open4, e005041 (2014). ArticlePubMedPubMed Central Google Scholar
McDonald-McGinn, D. M. et al. The perplexing prevalence of familial nested 22q11.2 deletions. ASGH[online], (2014).
Grati, F. R. et al. Prevalence of recurrent pathogenic microdeletions and microduplications in over 9500 pregnancies. Prenat. Diagn.35, 801–809 (2015). ArticlePubMed Google Scholar
Tomita-Mitchell A. et al. Multiplexed quantitative real-time PCR to detect 22q11.2 deletion in patients with congenital heart disease. Physiol. Genomics42A 52–60 (2010). ArticleCASPubMedPubMed Central Google Scholar
Chien, Y. H. et al. Incidence of severe combined immunodeficiency through newborn screening in a Chinese population. J. Formos. Med. Assoc.114, 12–16 (2015). ArticlePubMed Google Scholar
Kaminsky, E. B. et al. An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. Genet. Med.13, 777–784 (2011). ArticlePubMedPubMed Central Google Scholar
Schwinger, E., Devriendt, K., Rauch, A. & Philip, N. Clinical utility gene card for: DiGeorge syndrome, velocardiofacial syndrome, Shprintzen syndrome, chromosome 22q11.2 deletion syndrome (22q11.2, TBX1). Eur. J. Hum. Genet.http://dx.doi.org/10.1038/ejhg.2010.5 (2010).
McDonald-McGinn, D. M. et al. The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet. Couns.10, 11–24 (1999). This paper and references 20 and 29 were the first to outline the broad scope and breadth of features associated with 22q11.2DS, both in a large cohort of patients as well as in affected family members. CASPubMed Google Scholar
Delio, M. et al. Enhanced maternal origin of the 22q11.2 deletion in velocardiofacial and DiGeorge syndromes. Am. J. Hum. Genet.92, 439–447 (2013). ArticleCASPubMedPubMed Central Google Scholar
McDonald-McGinn, D. M. et al. The 22q11.2 deletion in African-American patients: an underdiagnosed population? Am. J. Med. Genet. A134, 242–246 (2005). ArticlePubMedPubMed Central Google Scholar
Liu, A. P. et al. Under-recognition of 22q11.2 deletion in adult Chinese patients with conotruncal anomalies: implications in transitional care. Eur. J. Med. Genet.57, 306–311 (2014). ArticlePubMed Google Scholar
Goldmuntz, E. et al. Microdeletions of chromosomal region 22q11 in patients with congenital conotruncal cardiac defects. J. Med. Genet.30, 807–812 (1993). ArticleCASPubMedPubMed Central Google Scholar
Peyvandi, S. et al. 22q11.2 deletions in patients with conotruncal defects: data from 1,610 consecutive cases. Pediatr. Cardiol.34, 1687–1694 (2013). ArticlePubMedPubMed Central Google Scholar
Zori, R. T. et al. Prevalence of 22q11 region deletions in patients with velopharyngeal insufficiency. Am. J. Med. Genet.77, 8–11 (1998). ArticleCASPubMed Google Scholar
Boorman, J. G., Varma, S. & Mackie Ogilvie, C. Velopharyngeal incompetence and chromosome 22q11 deletion. Lancet357, 774 (2001). ArticleCASPubMed Google Scholar
Ruiter, E. M., Bongers, E. M., Smeets, D., Kuijpers-Jagtman, A. M. & Hamel, B. C. No justification of routine screening for 22q11 deletions in patients with overt cleft palate. Clin. Genet.64, 216–219 (2003). ArticleCASPubMed Google Scholar
Rauch, A. et al. Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation. Am. J. Med. Genet.140, 2063–2074 (2006). ArticlePubMed Google Scholar
Bassett, A. S. et al. Clinically detectable copy number variations in a Canadian catchment population of schizophrenia. J. Psychiatr. Res.44, 1005–1009 (2010). ArticlePubMedPubMed Central Google Scholar
Horowitz, A., Shifman, S., Rivlin, N., Pisante, A. & Darvasi, A. A survey of the 22q11 microdeletion in a large cohort of schizophrenia patients. Schizophr. Res.73, 263–267 (2005). ArticlePubMed Google Scholar
Bassett, A. S. et al. Premature death in adults with 22q11.2 deletion syndrome. J. Med. Genet.46, 324–330 (2009). This paper was the first to systematically study mortality in adults with 22q11.2DS, identifying shortened longevity as an issue. ArticleCASPubMed Google Scholar
Edelmann, L., Pandita, R. K. & Morrow, B. E. Low-copy repeats mediate the common 3-Mb deletion in patients with velo-cardio-facial syndrome. Am. J. Hum. Genet.64, 1076–1086 (1999). The molecular mechanism responsible for chromosome rearrangements leading to the 22q11.2 deletion was identified. Thede novodeletion is caused by non-allelic recombination events between flanking LCRs during meiosis. ArticleCASPubMedPubMed Central Google Scholar
Shaikh, T. H. et al. Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. Hum. Mol. Genet.9, 489–501 (2000). ArticleCASPubMed Google Scholar
Saitta, S. C. et al. Aberrant interchromosomal exchanges are the predominant cause of the 22q11.2 deletion. Hum. Mol. Genet.13, 417–428 (2004). ArticleCASPubMed Google Scholar
Bailey, J. A. et al. Human-specific duplication and mosaic transcripts: the recent paralogous structure of chromosome 22. Am. J. Hum. Genet.70, 83–100 (2002). ArticleCASPubMed Google Scholar
Babcock, M. et al. Shuffling of genes within low-copy repeats on 22q11 (LCR22) by _Alu_-mediated recombination events during evolution. Genome Res.13, 2519–2532 (2003). ArticleCASPubMedPubMed Central Google Scholar
Morrow, B. et al. Molecular definition of the 22q11 deletions in velo-cardio-facial syndrome. Am. J. Hum. Genet.56, 1391–1403 (1995). CASPubMedPubMed Central Google Scholar
Rump, P. et al. Central 22q11.2 deletions. Am. J. Med. Genet. A164A, 2707–2723 (2014). Importantly, this paper reports cases of nested deletions of LCR22B–LCR22D, LCR22C–LCR22D and beyond, demonstrating that genes within the LCR22B–LCR22D regions result in features typically associated with the full LCR22A–LCR22D deletion. ArticleCASPubMed Google Scholar
Chaisson, M. J. et al. Resolving the complexity of the human genome using single-molecule sequencing. Nature517, 608–611 (2015). ArticleCASPubMed Google Scholar
Ellegood, J. et al. Neuroanatomical phenotypes in a mouse model of the 22q11.2 microdeletion. Mol. Psychiatry19, 99–107 (2014). ArticleCASPubMed Google Scholar
Mukai, J. et al. Molecular substrates of altered axonal growth and brain connectivity in a mouse model of schizophrenia. Neuron86, 680–695 (2015). ArticleCASPubMedPubMed Central Google Scholar
Earls, L. R. & Zakharenko, S. S. A synaptic function approach to investigating complex psychiatric diseases. Neuroscientist20, 257–271 (2013). ArticleCASPubMedPubMed Central Google Scholar
Karpinski, B. A. et al. Dysphagia and disrupted cranial nerve development in a mouse model of DiGeorge (22q11) deletion syndrome. Dis. Model. Mech.7, 245–257 (2014). ArticleCASPubMed Google Scholar
Meechan, D. W., Maynard, T. M., Tucker, E. S. & Lamantia, A. S. Three phases of DiGeorge/22q11 deletion syndrome pathogenesis during brain development: patterning, proliferation, and mitochondrial functions of 22q11 genes. Int. J. Dev. Neurosci.29, 283–294 (2011). ArticleCASPubMed Google Scholar
Zhang, Z. & Baldini, A. In vivo response to high-resolution variation of Tbx1 mRNA dosage. Hum. Mol. Genet.17, 150–157 (2008). In this article, mouse models were used to demonstrate thatTbx1function in individual tissues during embryonic development is sensitive to altered gene dosage. ArticleCASPubMed Google Scholar
Meechan, D. W., Maynard, T. M., Gopalakrishna, D., Wu, Y. & LaMantia, A. S. When half is not enough: gene expression and dosage in the 22q11 deletion syndrome. Gene Expr.13, 299–310 (2007). This review paper discusses the importance of gene dosage and 22q11.2DS. ArticleCASPubMed Google Scholar
McDonald-McGinn, D. M. et al. Hemizygous mutations in SNAP29 unmask autosomal recessive conditions and contribute to atypical findings in patients with 22q11.2DS. J. Med. Genet.50, 80–90 (2013). ArticleCASPubMed Google Scholar
Amati, F. et al. Dynamic changes in gene expression profiles of 22q11 and related orthologous genes during mouse development. Gene391, 91–102 (2007). ArticleCASPubMed Google Scholar
Guris, D. L., Duester, G., Papaioannou, V. E. & Imamoto, A. Dose-dependent interaction of Tbx1 and Crkl and locally aberrant RA signaling in a model of del22q11 syndrome. Dev. Cell10, 81–92 (2006). This article shows that bothTbx1andCrklgenetically interact in mouse models during cardiac, thymus and parathyroid gland development. ArticleCASPubMed Google Scholar
Earls, L. R. et al. Age-dependent microRNA control of synaptic plasticity in 22q11 deletion syndrome and schizophrenia. J. Neurosci.32, 14132–14144 (2012). ArticleCASPubMedPubMed Central Google Scholar
Zhao, D. et al. MicroRNA profiling of neurons generated using induced pluripotent stem cells derived from patients with schizophrenia and schizoaffective disorder, and 22q11.2 del. PLoS ONE10, e0132387 (2015). ArticleCASPubMedPubMed Central Google Scholar
Bassett, A. S., Marshall, C. R., Lionel, A. C., Chow, E. W. & Scherer, S. W. Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome. Hum. Mol. Genet.17, 4045–4053 (2008). ArticleCASPubMedPubMed Central Google Scholar
Swillen, A. et al. The behavioural phenotype in velo-cardio-facial syndrome (VCFS): from infancy to adolescence. Genet. Couns.10, 79–88 (1999). CASPubMed Google Scholar
Arnold, J. S. et al. Inactivation of Tbx1 in the pharyngeal endoderm results in 22q11DS malformations. Development133, 977–987 (2006). ArticleCASPubMed Google Scholar
Meechan, D. W. et al. Modeling a model: mouse genetics, 22q11.2 deletion syndrome, and disorders of cortical circuit development. Prog. Neurobiol.130, 1–28 (2015). ArticleCASPubMedPubMed Central Google Scholar
Sivagnanasundaram, S. et al. Differential gene expression in the hippocampus of the Df1/+ mice: a model for 22q11.2 deletion syndrome and schizophrenia. Brain Res.1139, 48–59 (2007). ArticleCASPubMed Google Scholar
Xu, B., Hsu, P. K., Stark, K. L., Karayiorgou, M. & Gogos, J. A. Derepression of a neuronal inhibitor due to miRNA dysregulation in a schizophrenia-related microdeletion. Cell152, 262–275 (2013). ArticleCASPubMedPubMed Central Google Scholar
Xu, B., Karayiorgou, M. & Gogos, J. A. MicroRNAs in psychiatric and neurodevelopmental disorders. Brain Res.1338, 78–88 (2010). ArticleCASPubMed Google Scholar
Zou, D. et al. Patterning of the third pharyngeal pouch into thymus/parathyroid by Six and Eya1. Dev. Biol.293, 499–512 (2006). ArticleCASPubMed Google Scholar
Kelly, R. G., Buckingham, M. E. & Moorman, A. F. Heart fields and cardiac morphogenesis. Cold Spring Harb. Perspect. Med.4, a015750 (2014). The heart fields are crucial to form the aortic arch and conotruncal region of the heart, which are affected in 22q11.2DS. This paper explains the importance of the second heart field. ArticleCASPubMedPubMed Central Google Scholar
Milgrom-Hoffman, M., Michailovici, I., Ferrara, N., Zelzer, E. & Tzahor, E. Endothelial cells regulate neural crest and second heart field morphogenesis. Biol. Open3, 679–688 (2014). ArticleCASPubMedPubMed Central Google Scholar
Keyte, A. L., Alonzo-Johnsen, M. & Hutson, M. R. Evolutionary and developmental origins of the cardiac neural crest: building a divided outflow tract. Birth Defects Res. C Embryo Today102, 309–323 (2014). ArticleCASPubMedPubMed Central Google Scholar
Neeb, Z., Lajiness, J. D., Bolanis, E. & Conway, S. J. Cardiac outflow tract anomalies. Wiley Interdiscip. Rev. Dev. Biol.2, 499–530 (2013). ArticleCASPubMedPubMed Central Google Scholar
Lewin, M. B. et al. A genetic etiology for interruption of the aortic arch type B. Am. J. Cardiol.80, 493–497 (1997). ArticleCASPubMed Google Scholar
Guna, A., Butcher, N. J. & Bassett, A. S. Comparative mapping of the 22q11.2 deletion region and the potential of simple model organisms. J. Neurodev. Disord.7, 18 (2015). ArticlePubMedPubMed Central Google Scholar
Jerome, L. A. & Papaioannou, V. E. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat. Genet.27, 286–291 (2001). By using mouse model approaches,Tbx1was found to be required for craniofacial, thymus and parathyroid gland as well as cardiac development. This is a seminal paper in the field. ArticleCASPubMed Google Scholar
Merscher, S. et al. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell104, 619–629 (2001). ArticleCASPubMed Google Scholar
Lindsay, E. A. et al. Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature410, 97–101 (2001). ArticleCASPubMed Google Scholar
Zhang, Z. et al. Tbx1 expression in pharyngeal epithelia is necessary for pharyngeal arch artery development. Development132, 5307–5315 (2005). ArticleCASPubMed Google Scholar
Zhang, Z., Huynh, T. & Baldini, A. Mesodermal expression of Tbx1 is necessary and sufficient for pharyngeal arch and cardiac outflow tract development. Development133, 3587–3595 (2006). ArticleCASPubMed Google Scholar
Papangeli, I. & Scambler, P. The 22q11 deletion: DiGeorge and velocardiofacial syndromes and the role of TBX1. Wiley Interdiscip. Rev. Dev. Biol.2, 393–403 (2013). ArticleCASPubMed Google Scholar
Calmont, A. et al. Tbx1 controls cardiac neural crest cell migration during arch artery development by regulating Gbx2 expression in the pharyngeal ectoderm. Development136, 3173–3183 (2009). In mice, the gastrulation brain homeobox 2 (Gbx2) gene was found to be crucial in the pharyngeal ectoderm to signal to adjacent neural crest cells, which was required to form the aortic arch and branching vessels. ArticleCASPubMedPubMed Central Google Scholar
Vitelli, F., Morishima, M., Taddei, I., Lindsay, E. A. & Baldini, A. Tbx1 mutation causes multiple cardiovascular defects and disrupts neural crest and cranial nerve migratory pathways. Hum. Mol. Genet.11, 915–922 (2002). ArticleCASPubMed Google Scholar
Caprio, C. & Baldini, A. p53 suppression partially rescues the mutant phenotype in mouse models of DiGeorge syndrome. Proc. Natl Acad. Sci. USA111, 13385–13390 (2014). Genetic rescue is the gold standard for future therapeutics for 22q11.2DS. This is the first paper demonstrating that genetic rescue can take place by reducing the levels of p53. ArticleCASPubMedPubMed Central Google Scholar
Paylor, R. et al. Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc. Natl Acad. Sci. USA103, 7729–7734 (2006). ArticleCASPubMedPubMed Central Google Scholar
Stark, K. L. et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat. Genet.40, 751–760 (2008). ArticleCASPubMed Google Scholar
Chapnik, E., Sasson, V., Blelloch, R. & Hornstein, E. Dgcr8 controls neural crest cells survival in cardiovascular development. Dev. Biol.362, 50–56 (2012). ArticleCASPubMed Google Scholar
Petri, R., Malmevik, J., Fasching, L., Akerblom, M. & Jakobsson, J. miRNAs in brain development. Exp. Cell Res.321, 84–89 (2014). ArticleCASPubMed Google Scholar
Beveridge, N. J., Gardiner, E., Carroll, A. P., Tooney, P. A. & Cairns, M. J. Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol. Psychiatry15, 1176–1189 (2010). ArticleCASPubMed Google Scholar
Merico, D. et al. MicroRNA dysregulation, gene networks, and risk for schizophrenia in 22q11.2 deletion syndrome. Front. Neurol.5, 238 (2014). ArticlePubMedPubMed Central Google Scholar
Sellier, C. et al. Decreased DGCR8 expression and miRNA dysregulation in individuals with 22q11.2 deletion syndrome. PLoSONE9, e103884 (2014). ArticleCAS Google Scholar
Guris, D. L., Fantes, J., Tara, D., Druker, B. J. & Imamoto, A. Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome. Nat. Genet.27, 293–298 (2001). This paper shows that, in addition toTbx1, inactivation ofCrklon 22q11.2 can result in physical malformations observed in 22q11.2DS. ArticleCASPubMed Google Scholar
Racedo, S. E. et al. Mouse and human CRKL is dosage sensitive for cardiac outflow tract formation. Am. J. Hum. Genet.96, 235–244 (2015). The combination of human and mouse genetics has shed new light on the function ofCRKLin the formation of the cardiac outflow tract. ArticleCASPubMedPubMed Central Google Scholar
Zheng, P. et al. Molecular mechanisms of functional natural killer deficiency in patients with partial DiGeorge syndrome. J. Allergy Clin. Immunol.135, 1293–1302 (2015). ArticleCASPubMedPubMed Central Google Scholar
Bedeschi, M. F. et al. Unmasking of a recessive SCARF2 mutation by a 22q11.12 de novo deletion in a patient with Van den Ende–Gupta syndrome. Mol. Syndromol.1, 239–245 (2010). ArticleCASPubMed Google Scholar
Bassett, A. S., Caluseriu, O., Weksberg, R., Young, D. A. & Chow, E. W. Catechol-_O_-methyl transferase and expression of schizophrenia in 73 adults with 22q11 deletion syndrome. Biol. Psychiatry61, 1135–1140 (2007). ArticleCASPubMedPubMed Central Google Scholar
Murphy, K. C., Jones, L. A. & Owen, M. J. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch. Gen. Psychiatry56, 940–945 (1999). ArticleCASPubMed Google Scholar
Gothelf, D. et al. Risk factors and the evolution of psychosis in 22q11.2 deletion syndrome: a longitudinal 2-site study. J. Am. Acad. Child Adolesc. Psychiatry52, 1192–1203.e3 (2013). ArticlePubMed Google Scholar
Philip, N. & Bassett, A. S. Cognitive, behavioural and psychiatric phenotype in 22q11.2 deletion syndrome. Behav. Genet.41, 403–412 (2011). ArticlePubMedPubMed Central Google Scholar
Goodman, B. K., Rutberg, J., Lin, W. W., Pulver, A. E. & Thomas, G. H. Hyperprolinaemia in patients with deletion (22)(q11.2) syndrome. J. Inherit. Metab. Dis.23, 847–848 (2000). ArticleCASPubMed Google Scholar
Magnée, M. J., Lamme, V. A., de Sain-van der Velden, M. G., Vorstman, J. A. & Kemner, C. Proline and COMT status affect visual connectivity in children with 22q11.2 deletion syndrome. PLoSONE6, e25882 (2011). ArticleCAS Google Scholar
Paronett, E. M., Meechan, D. W., Karpinski, B. A., LaMantia, A.-S. & Maynard, T. M. Ranbp1, deleted in DiGeorge/22q11.2 deletion syndrome, is a microcephaly gene that selectively disrupts layer 2/3 cortical projection neuron generation. Cereb. Cortex25, 3977–3993 (2014). ArticlePubMedPubMed Central Google Scholar
Raux, G. et al. Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. Hum. Mol. Genet.16, 83–91 (2007). ArticleCASPubMed Google Scholar
Vorstman, J. A. S. et al. Proline affects brain function in 22q11DS children with the low activity _COMT_158 allele. Neuropsychopharmacology34, 739–746 (2008). ArticleCASPubMed Google Scholar
Newbern, J. et al. Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest development. Proc. Natl Acad. Sci. USA105, 17115–17120 (2008). ArticlePubMedPubMed Central Google Scholar
Dykes, I. M. et al. HIC2 is a novel dosage-dependent regulator of cardiac development located within the distal 22q11 deletion syndrome region. Circ. Res.115, 23–31 (2014). ArticleCASPubMed Google Scholar
Toritsuka, M. et al. Deficits in microRNA-mediated Cxcr4/Cxcl12 signaling in neurodevelopmental deficits in a 22q11 deletion syndrome mouse model. Proc. Natl Acad. Sci. USA110, 17552–17557 (2013). ArticlePubMedPubMed Central Google Scholar
Swaby, J. A. et al. Complex congenital heart disease in unaffected relatives of adults with 22q11.2 deletion syndrome. Am. J. Cardiol.107, 466–471 (2011). ArticleCASPubMedPubMed Central Google Scholar
Merico, D. et al. Whole-genome sequencing suggests schizophrenia risk mechanisms in humans with 22q11.2 deletion syndrome. G3(Bethesda)5, 2453–2461 (2015). ArticleCASPubMedPubMed Central Google Scholar
Swillen, A. & McDonald-McGinn, D. Developmental trajectories in 22q11.2 deletion syndrome. Am. J. Med. Genet. C Semin. Med. Genet.169, 172–181 (2015). This paper provides a current state of the art perspective on developmental trajectories with appropriate interventions. ArticleCASPubMedPubMed Central Google Scholar
Fung, W. L. et al. Practical guidelines for managing adults with 22q11.2 deletion syndrome. Genet. Med.17, 599–609 (2015). This paper (for adults) and reference 22 (for children) provide a comprehensive overview of all domains to be covered in the multidisciplinary management of patients with 22q11.2DS. ArticleCASPubMedPubMed Central Google Scholar
Vergaelen, E. et al. 3 generation pedigree with paternal transmission of the 22q11.2 deletion syndrome: intrafamilial phenotypic variability. Eur. J. Med. Genet.58, 244–248 (2015). ArticlePubMed Google Scholar
McElhinney, D. B., McDonald-McGinn, D., Zackai, E. H. & Goldmuntz, E. Cardiovascular anomalies in patients diagnosed with a chromosome 22q11 deletion beyond 6 months of age. Pediatrics108, E104 (2001). ArticleCASPubMed Google Scholar
John, A. S., McDonald-McGinn, D. M., Zackai, E. H. & Goldmuntz, E. Aortic root dilation in patients with 22q11.2 deletion syndrome. Am. J. Med. Genet. A149A, 939–942 (2009). ArticlePubMed Google Scholar
Piliero, L. M., Sanford, A. N., McDonald-McGinn, D. M., Zackai, E. H. & Sullivan, K. E. T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome. Blood103, 1020–11025 (2004). The consequences of thymic hypoplasia were elucidated in this paper. It highlights the dynamic nature of immunodeficiency over time in this syndrome. ArticleCASPubMed Google Scholar
Sullivan, K. E. et al. Lack of correlation between impaired T cell production, immunodeficiency, and other phenotypic features in chromosome 22q11.2 deletion syndromes. Clin. Immunol. Immunopathol.86, 141–146 (1998). ArticleCASPubMed Google Scholar
Sullivan, K. E., McDonald-McGinn, D. & Zackai, E. H. CD4+CD25+ T-cell production in healthy humans and in patients with thymic hypoplasia. Clin. Diagn. Lab. Immunol.9, 1129–1131 (2002). PubMedPubMed Central Google Scholar
Sullivan, K. E. et al. Longitudinal analysis of lymphocyte function and numbers in the first year of life in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin. Diagn. Lab. Immunol.6, 906–911 (1999). CASPubMedPubMed Central Google Scholar
Jawad, A. F. et al. A prospective study of influenza vaccination and a comparison of immunologic parameters in children and adults with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). J. Clin. Immunol.31, 927–935 (2011). ArticleCASPubMedPubMed Central Google Scholar
Perez, E. E., Bokszczanin, A., McDonald-McGinn, D., Zackai, E. H. & Sullivan, K. E. Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Pediatrics112, e325 (2003). ArticlePubMed Google Scholar
Smith, C. A. et al. Increased prevalence of immunoglobulin A deficiency in patients with the chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin. Diagn. Lab. Immunol.5, 415–417 (1998). CASPubMedPubMed Central Google Scholar
Staple, L., Andrews, T., McDonald-McGinn, D., Zackai, E. & Sullivan, K. E. Allergies in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) and patients with chronic granulomatous disease. Pediatr. Allergy Immunol.16, 226–230 (2005). ArticlePubMed Google Scholar
Zemble, R. et al. Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin. Immunol.136, 409–418 (2010). ArticleCASPubMedPubMed Central Google Scholar
Sullivan, K. E. et al. Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad/velocardiofacial syndrome/conotruncal anomaly face syndrome). Arthritis Rheum.40, 430–436 (1997). ArticleCASPubMed Google Scholar
Lawrence, S., McDonald-McGinn, D. M., Zackai, E. & Sullivan, K. E. Thrombocytopenia in patients with chromosome 22q11.2 deletion syndrome. J. Pediatr.143, 277–278 (2003). ArticlePubMed Google Scholar
Kratz, C. P. et al. Evans syndrome in a patient with chromosome 22q11.2 deletion syndrome: a case report. Pediatr. Hematol. Oncol.20, 167–172 (2003). ArticleCASPubMed Google Scholar
Kawame, H. et al. Graves' disease in patients with 22q11.2 deletion. J. Pediatr.139, 892–895 (2001). ArticleCASPubMed Google Scholar
Bale, P. M. & Sotelo-Avila, C. Maldescent of the thymus: 34 necropsy and 10 surgical cases, including 7 thymuses medial to the mandible. Pediatr. Pathol.13, 181–190 (1993). ArticleCASPubMed Google Scholar
Chinen, J., Rosenblatt, H. M., Smith, E. O., Shearer, W. T. & Noroski, L. M. Long-term assessment of T-cell populations in DiGeorge syndrome. J. Allergy Clin. Immunol.111, 573–579 (2003). ArticlePubMed Google Scholar
Dyce, O. et al. Otolaryngologic manifestations of the 22q11.2 deletion syndrome. Arch. Otolaryngol. Head Neck Surg.128, 1408–1412 (2002). ArticlePubMed Google Scholar
Hamilton, S., Husein, M. & Dworschak-Stokan, A. Velopharyngeal insufficiency clinic: the first 18 months. J. Otolaryngol. Head Neck Surg.37, 586–590 (2008). PubMed Google Scholar
Solot, C. B. et al. Communication issues in 22q11.2 deletion syndrome: children at risk. Genet. Med.3, 67–71 (2001). ArticleCASPubMed Google Scholar
Ruotolo, R. A. et al. Velopharyngeal anatomy in 22q11.2 deletion syndrome: a three-dimensional cephalometric analysis. Cleft Palate Craniofac. J.43, 446–456 (2006). ArticlePubMedPubMed Central Google Scholar
Widdershoven, J. C. et al. A candidate gene approach to identify modifiers of the palatal phenotype in 22q11.2 deletion syndrome patients. Int. J. Pediatr. Otorhinolaryngol.77, 123–127 (2013). ArticlePubMed Google Scholar
Stransky, C. et al. Perioperative risk factors in patients with 22q11.2 deletion syndrome requiring surgery for velopharyngeal dysfunction. Cleft Palate Craniofac. J.52, 183–191 (2015). ArticlePubMed Google Scholar
Forbes, B. J. et al. Ocular findings in the chromosome 22q11.2 deletion syndrome. J. AAPOS11, 179–182 (2007). ArticlePubMed Google Scholar
Cheung, E. N. et al. Prevalence of hypocalcemia and its associated features in 22q11.2 deletion syndrome. Clin. Endocrinol.81, 190–196 (2014). ArticleCAS Google Scholar
Weinzimer, S. A. Endocrine aspects of the 22q11.2 deletion syndrome. Genet. Med.3, 19–22 (2001). ArticleCASPubMed Google Scholar
Digilio, M. C. et al. Auxological evaluation in patients with DiGeorge/velocardiofacial syndrome (deletion 22q11.2 syndrome). Genet. Med.3, 30–33 (2001). ArticleCASPubMed Google Scholar
Habel, A., McGinn, M.-J. 2nd, Zackai, E. H., Unanue, N. & McDonald-McGinn, D. M. Syndrome-specific growth charts for 22q11.2 deletion syndrome in Caucasian children. Am. J. Med. Genet. A158A, 2665–2671 (2012). ArticleCASPubMed Google Scholar
Van, L. et al. Fetal growth and gestational factors as predictors of schizophrenia in 22q11.2 deletion syndrome. Genet. Med.http://dx.doi.org/10.1038/gim.2015.84 (2015).
Eicher, P. S. et al. Dysphagia in children with a 22q11.2 deletion: unusual pattern found on modified barium swallow. J. Pediatr.137, 158–164 (2000). ArticleCASPubMed Google Scholar
Digilio, M. C., Marino, B., Bagolan, P., Giannotti, A. & Dallapiccola, B. Microdeletion 22q11 and oesophageal atresia. J. Med. Genet.36, 137–139 (1999). CASPubMedPubMed Central Google Scholar
Oskarsdottir, S., Belfrage, M., Sandstedt, E., Viggedal, G. & Uvebrant, P. Disabilities and cognition in children and adolescents with 22q11 deletion syndrome. Dev. Med. Child Neurol.47, 177–184 (2005). ArticleCASPubMed Google Scholar
Wu, H.-Y. et al. Genitourinary malformations in chromosome 22q11.2 deletion. J. Urol.168, 2564–2565 (2002). ArticleCASPubMed Google Scholar
Devriendt, K., Swillen, A., Fryns, J. P., Proesmans, W. & Gewillig, M. Renal and urological tract malformations caused by a 22q11 deletion. J. Med. Genet.33, 349 (1996). ArticleCASPubMedPubMed Central Google Scholar
Sundaram, U. T. et al. Primary amenorrhea and absent uterus in the 22q11.2 deletion syndrome. Am. J. Med. Genet. A143A, 2016–2018 (2007). ArticleCASPubMedPubMed Central Google Scholar
Barnett, C., Langer, J. C., Hinek, A., Bradley, T. J. & Chitayat, D. Looking past the lump: genetic aspects of inguinal hernia in children. J. Pediatr. Surg.44, 1423–1431 (2009). ArticlePubMed Google Scholar
Binenbaum, G. et al. Sclerocornea associated with the chromosome 22q11.2 deletion syndrome. Am. J. Med. Genet. A146A, 904–909 (2008). ArticlePubMed Google Scholar
Bingham, P. M., Lynch, D., McDonald-McGinn, D. & Zackai, E. Polymicrogyria in chromosome 22 delection syndrome. Neurology51, 1500–1502 (1998). ArticleCASPubMed Google Scholar
Ming, J. E. et al. Skeletal anomalies and deformities in patients with deletions of 22q11. Am. J. Med. Genet.72, 210–215 (1997). ArticleCASPubMed Google Scholar
Ricchetti, E. T. et al. Radiographic study of the upper cervical spine in the 22q11.2 deletion syndrome. J. Bone Joint Surg. Am.86, 1751–1760 (2004). ArticlePubMed Google Scholar
McDonald-McGinn, D. M. et al. Malignancy in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Am. J. Med. Genet. A140, 906–909 (2006). ArticlePubMed Google Scholar
Butcher, N. et al. Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications. JAMA Neurol.70, 1359–1366 (2013). ArticlePubMedPubMed Central Google Scholar
Swillen, A. et al. Early motor development in young children with 22q.11 deletion syndrome and a conotruncal heart defect. Dev. Med. Child Neurol.47, 797–802 (2005). ArticlePubMed Google Scholar
Solot, C. B. et al. Communication disorders in the 22Q11.2 microdeletion syndrome. J. Commun. Disord.33, 187–203 (2000). ArticleCASPubMed Google Scholar
Swillen, A. et al. Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with VCFS. J. Med. Genet.34, 453–458 (1997). ArticleCASPubMedPubMed Central Google Scholar
De Smedt, B. et al. Intellectual abilities in a large sample of children with velo-cardio-facial syndrome: an update. J. Intellect. Disabil. Res.51, 666–670 (2007). ArticleCASPubMed Google Scholar
De Smedt, B., Swillen, A., Verschaffel, L. & Ghesquiere, P. Mathematical learning disabilities in children with 22q11.2 deletion syndrome: a review. Dev. Disabil. Res. Rev.15, 4–10 (2009). ArticlePubMed Google Scholar
Wang, P. P., Woodin, M. F., Kreps-Falk, R. & Moss, E. M. Research on behavioral phenotypes: velocardiofacial syndrome (deletion 22q11.2). Dev. Med. Child Neurol.42, 422–427 (2000). ArticleCASPubMed Google Scholar
Glaser, B. et al. Language skills in children with velocardiofacial syndrome (deletion 22q11.2). J. Pediatr.140, 753–758 (2002). ArticlePubMed Google Scholar
Evers, L. J. et al. Psychopathology in adults with 22q11 deletion syndrome and moderate and severe intellectual disability. J. Intellect. Disabil. Res.58, 915–925 (2014). ArticleCASPubMed Google Scholar
Cheung, E. N. et al. Neonatal hypocalcemia, neonatal seizures, and intellectual disability in 22q11.2 deletion syndrome. Genet. Med.16, 40–44 (2014). ArticleCASPubMed Google Scholar
Duijff, S. N. et al. Cognitive development in children with 22q11.2 deletion syndrome. Br. J. Psychiatry200, 462–468 (2012). This paper presents a longitudinal data study on cognitive development in a large cohort of children. ArticlePubMed Google Scholar
Vorstman, J. A. et al. Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome. JAMA Psychiatry72, 377–385 (2015). Using data from a large collaborative effort (The International 22q11.2 Brain and Behavior Consortium), this paper shows the association of cognitive decline as an antecedent to the onset of psychosis. Drawing from this same consortium, reference 182, reports on the psychiatric disorders observed in this population. ArticlePubMedPubMed Central Google Scholar
Schneider, M. et al. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 deletion syndrome. Am. J. Psychiatry171, 627–639 (2014). ArticlePubMedPubMed Central Google Scholar
Fung, W. L. et al. Elevated prevalence of generalized anxiety disorder in adults with 22q11.2 deletion syndrome. Am. J. Psychiatry167, 998 (2010). ArticlePubMedPubMed Central Google Scholar
Amelsvoort, T. V. et al. Cognitive deficits associated with schizophrenia in velo-cardio-facial syndrome. Schizophr. Res.70, 223–232 (2004). ArticlePubMed Google Scholar
Chow, E. W., Watson, M., Young, D. A. & Bassett, A. S. Neurocognitive profile in 22q11 deletion syndrome and schizophrenia. Schizophr. Res.87, 270–278 (2006). ArticlePubMedPubMed Central Google Scholar
Stoddard, J., Niendam, T., Hendren, R., Carter, C. & Simon, T. J. Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome. Schizophr. Res.118, 118–121 (2010). ArticlePubMedPubMed Central Google Scholar
Butcher, N. J. et al. Response to clozapine in a clinically identifiable subtype of schizophrenia. Br. J. Psychiatry206, 484–491 (2015). This paper is notable as it is the first report on the functional outcome of a large group (>100 subjects) of adults with 22q11.2 DS.
Baker, K. & Vorstman, J. A. S. Is there a core neuropsychiatric phenotype in 22q11.2 deletion syndrome? Curr. Opin. Neurol.25, 131–137 (2012). ArticleCASPubMed Google Scholar
Chan, C., Costain, G., Chow, E. W. C. & Bassett, A. S. Reproductive health issues for adults with a common genomic disorder. J. Genet. Couns.24, 810–821 (2015). ArticlePubMedPubMed Central Google Scholar
Balci, A. et al. Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease. Heart100, 1373–1381 (2014). ArticlePubMed Google Scholar
Grewal, J., Silversides, C. K. & Colman, J. M. Pregnancy in women with heart disease: risk assessment and management of heart failure. Heart Fail. Clin.10, 117–129 (2014). ArticlePubMed Google Scholar
Sorensen, K. M. et al. Detecting 22q11.2 deletions by use of multiplex ligation-dependent probe amplification on DNA from neonatal dried blood spot samples. J. Mol. Diagn.12, 147–151 (2010). ArticleCASPubMedPubMed Central Google Scholar
Vorstman, J. A. et al. MLPA: a rapid, reliable, and sensitive method for detection and analysis of abnormalities of 22q. Hum. Mut.27, 814–821 (2006). ArticleCASPubMed Google Scholar
Sandrin-Garcia, P. et al. Recurrent 22q11.2 deletion in a sibship suggestive of parental germline mosaicism in velocardiofacial syndrome. Clin. Genet.61, 380–383 (2002). ArticleCASPubMed Google Scholar
Gross, S. J. et al. Clinical experience with single-nucleotide polymorphism-based noninvasive prenatal screening for 22q11.2 deletion syndrome. Ultrasound Obstet. Gynecol.http://dx.doi.org/10.1002/uog.15754 (2015).
Bretelle, F. et al. Prenatal and postnatal diagnosis of 22q11.2 deletion syndrome. Eur. J. Med. Genet.53, 367–370 (2010). ArticlePubMed Google Scholar
Carotti, A. et al. Cardiac defects and results of cardiac surgery in 22q11.2 deletion syndrome. Dev. Disabil. Res. Rev.14, 35–42 (2008). ArticlePubMed Google Scholar
Michielon, G. et al. Impact of DEL22q11, trisomy 21, and other genetic syndromes on surgical outcome of conotruncal heart defects. J. Thorac. Cardiovasc. Surg.138, 565–570.e2 (2009). ArticleCASPubMed Google Scholar
Mercer-Rosa, L., Pinto, N., Yang, W., Tanel, R. & Goldmuntz, E. 22q11.2 deletion syndrome is associated with perioperative outcome in tetralogy of Fallot. J. Thorac. Cardiovasc. Surg.146, 868–873 (2013). ArticleCASPubMedPubMed Central Google Scholar
O'Byrne, M. L. et al. 22q11.2 deletion syndrome is associated with increased perioperative events and more complicated postoperative course in infants undergoing infant operative correction of truncus arteriosus communis or interrupted aortic arch. J. Thorac. Cardiovasc. Surg.148, 1597–1605 (2014). ArticleCASPubMedPubMed Central Google Scholar
Warnes, C. A. et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. College Cardiol.52, e143–e263 (2008). Article Google Scholar
Lin, A. E. et al. Adults with genetic syndromes and cardiovascular abnormalities: clinical history and management. Genet. Med.10, 469–494 (2008). ArticlePubMedPubMed Central Google Scholar
Hofstetter, A. M. et al. Live vaccine use and safety in DiGeorge syndrome. Pediatrics133, e946–e954 (2014). ArticlePubMed Google Scholar
Moylett, E. H., Wasan, A. N., Noroski, L. M. & Shearer, W. T. Live viral vaccines in patients with partial DiGeorge syndrome: clinical experience and cellular immunity. Clin. Immunol.112, 106–112 (2004). This paper and reference 135 were the first to define the safety of live viral vaccines in this syndrome. ArticleCASPubMed Google Scholar
Bjork, A. H., Oskarsdottir, S., Andersson, B. A. & Friman, V. Antibody deficiency in adults with 22q11.2 deletion syndrome. Am. J. Med. Genet. A158A, 1934–1940 (2012). ArticleCASPubMed Google Scholar
Maggadottir, S. M. & Sullivan, K. E. The diverse clinical features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome). J. Allergy Clin. Immunol. Pract.1, 589–594 (2013). ArticlePubMed Google Scholar
Basta, M. N. et al. A 35-year experience with syndromic cleft palate repair: operative outcomes and long-term speech function. Ann. Plast. Surg.73, S130–S135 (2014). ArticleCASPubMed Google Scholar
Kennedy, W. P. et al. 22q11.2 deletion syndrome and obstructive sleep apnea. Int. J. Pediatr. Otorhinolaryngol.78, 1360–1364 (2014). ArticlePubMed Google Scholar
Sobin, C., Monk, S. H., Kiley-Brabeck, K., Khuri, J. & Karayiorgou, M. Neuromotor deficits in children with the 22q11 deletion syndrome. Mov. Disord.21, 2082–2089 (2006). ArticlePubMedPubMed Central Google Scholar
Van Aken, K., Caeyenberghs, K., Smits-Engelsman, B. & Swillen, A. The motor profile of primary school-age children with a 22q11.2 deletion syndrome (22q11.2DS) and an age- and IQ-matched control group. Child Neuropsychol.15, 532–542 (2009). ArticlePubMed Google Scholar
Vorstman, J. A. S. et al. The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. J. Am. Acad. Child Adolesc. Psychiatry45, 1104–1113 (2006). ArticlePubMed Google Scholar
Dori, N., Green, T., Weizman, A. & Gothelf, D. The effectiveness and safety of antipsychotic and antidepressant medications in individuals with 22q11.2 deletion syndrome. J. ChildAdolesc.Psychopharmacol.http://dx.doi.org/10.1089/cap.2014.0075 (2015).
Gothelf, D. et al. Obsessive–compulsive disorder in patients with velocardiofacial (22q11 deletion) syndrome. Am. J. Med. Genet. B Neuropsychiatr. Genet.126B, 99–105 (2004). ArticlePubMed Google Scholar
Gothelf, D. et al. Methylphenidate treatment for attention-deficit/hyperactivity disorder in children and adolescents with velocardiofacial syndrome: an open-label study. J. Clin. Psychiatry64, 1163–1169 (2003). ArticleCASPubMed Google Scholar
Karas, D. J., Costain, G., Chow, E. W. & Bassett, A. S. Perceived burden and neuropsychiatric morbidities in adults with 22q11.2 deletion syndrome. J. Intellect. Disabil. Res.58, 198–210 (2014). ArticleCASPubMed Google Scholar
Mercer-Rosa, L. et al. 22q11.2 deletion status and disease burden in children and adolescents with tetralogy of Fallot. Circ. Cardiovasc. Genet.8, 74–81 (2015). ArticleCASPubMedPubMed Central Google Scholar
Briegel, W., Schneider, M. & Schwab, K. O. 22q11.2 deletion: handicap-related problems and coping strategies of primary caregivers. Z. Kinder Jugendpsychiatr. Psychother.37, 535–540 (in German) (2009). ArticlePubMed Google Scholar
Looman, W. S., Thurmes, A. K. & O'Conner-Von, S. K. Quality of life among children with velocardiofacial syndrome. Cleft Palate Craniofac. J.47, 273–283 (2010). ArticlePubMedPubMed Central Google Scholar
Mahle, W. T. et al. Deletion of chromosome 22q11.2 and outcome in patients with pulmonary atresia and ventricular septal defect. Ann. Thorac. Surg.76, 567–571 (2003). ArticlePubMed Google Scholar
Woodin, M. et al. Neuropsychological profile of children and adolescents with the 22q11.2 microdeletion. Genet. Med.3, 34–39 (2001). ArticleCASPubMed Google Scholar
Jacobson, C. et al. Core neuropsychological characteristics of children and adolescents with 22q11.2 deletion. J. Intellectual Disabil. Res.54, 701–713 (2010). ArticleCAS Google Scholar
Driscoll, D. A. Molecular and genetic aspects of DiGeorge/velocardiofacial syndrome. Methods Mol. Med.126, 43–55 (2006). CASPubMed Google Scholar
Mlynarski, E. E. et al. Copy-number variation of the glucose transporter gene SLC2A3 and congenital heart defects in the 22q11.2 deletion syndrome. Am. J. Hum. Genet.96, 753–764 (2015). ArticleCASPubMedPubMed Central Google Scholar
Chung, J. H. et al. Whole-genome sequencing and integrative genomic analysis approach on two 22q11.2 deletion syndrome family trios for genotype to phenotype correlations. Hum. Mut.36, 797–807 (2015). ArticleCASPubMed Google Scholar
Guo, T. et al. Genotype and cardiovascular phenotype correlations with _TBX_n 1,022 velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome patients. Hum. Mut.32, 1278–1289 (2011). ArticleCASPubMed Google Scholar
Budarf, M. L. et al. Identification of a patient with Bernard–Soulier syndrome and a deletion in the DiGeorge/velo-cardio-facial chromosomal region in 22q11.2. Hum. Mol. Genet.4, 763–766 (1995). This paper and reference 68 highlight the possibility of unmasking an autosomal recessive condition to explain atypical phenotypes and to identify important genes associated with 22q11.2DS beyondTBX1. ArticleCASPubMed Google Scholar
Wapner, R. J. et al. Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes. Am. J. Obstet. Gynecol.212, 332.e1–332.e9 (2015). Article Google Scholar
Vialard, F. et al. Prenatal BACs-on-BeadsTM: the prospective experience of five prenatal diagnosis laboratories. Prenat. Diagn.32, 329–335 (2012). ArticleCASPubMed Google Scholar
Koontz, D., Baecher, K., Kobrynski, L., Nikolova, S. & Gallagher, M. A pyrosequencing-based assay for the rapid detection of the 22q11.2 deletion in DNA from buccal and dried blood spot samples. J. Mol. Diagn.16, 533–540 (2014). ArticleCASPubMed Google Scholar
Pretto, D., Maar, D., Yrigollen, C. M., Regan, J. & Tassone, F. Screening newborn blood spots for 22q11.2 deletion syndrome using multiplex droplet digital PCR. Clin. Chem.61, 182–190 (2015). ArticleCASPubMed Google Scholar